Literature DB >> 26825179

Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus.

P Elliott Miller1, Sabina A Haberlen, Todd T Brown, Joseph B Margolick, Joseph A DiDonato, Stanley L Hazen, Mallory D Witt, Lawrence A Kingsley, Frank J Palella, Matthew Budoff, Lisa P Jacobson, Wendy S Post, Cynthia L Sears.   

Abstract

Recent evidence has shown a complex relationship between the gut microbiota, dietary nutrients, and cardiovascular disease (CVD). Trimethylamine-N-oxide (TMAO) production, initiated by the microbiota, has been associated with CVD events. We sought to test if this association exists in HIV-infected persons. After adjusting for aspirin use and CVD risk factors, HIV-infected men were more likely to have coronary stenosis in the second and third TMAO quartiles compared with the first quartile, but did not differ significantly in the fourth quartile. We found an inverted U-shaped association between TMAO levels and the presence of coronary artery stenosis among HIV-infected men.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26825179      PMCID: PMC4836953          DOI: 10.1097/QAI.0000000000000937

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  30 in total

1.  Associations between HIV infection and subclinical coronary atherosclerosis.

Authors:  Wendy S Post; Matthew Budoff; Lawrence Kingsley; Frank J Palella; Mallory D Witt; Xiuhong Li; Richard T George; Todd T Brown; Lisa P Jacobson
Journal:  Ann Intern Med       Date:  2014-04-01       Impact factor: 25.391

2.  Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.

Authors:  M Trøseid; T Ueland; J R Hov; A Svardal; I Gregersen; C P Dahl; S Aakhus; E Gude; B Bjørndal; B Halvorsen; T H Karlsen; P Aukrust; L Gullestad; R K Berge; A Yndestad
Journal:  J Intern Med       Date:  2014-12-01       Impact factor: 8.989

3.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

4.  Use of cardiac CT angiography imaging in an epidemiology study - the Methodology of the Multicenter AIDS Cohort Study cardiovascular disease substudy.

Authors:  Yalçın Hacıoğlu; Mohit Gupta; Tae Young Choi; Richard T George; Christopher R Deible; Lisa P Jacobson; Mallory D Witt; Frank J Palella; Wendy S Post; Matthew J Budoff
Journal:  Anadolu Kardiyol Derg       Date:  2013-01-30

5.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

Authors:  Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121

6.  Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection.

Authors:  Judith M Haissman; Andreas Knudsen; Hedda Hoel; Andreas Kjær; Ulrik S Kristoffersen; Rolf K Berge; Terese L Katzenstein; Asbjørn Svardal; Thor Ueland; Pål Aukrust; Anne-Mette Lebech; Susanne D Nielsen; Marius Trøseid
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

7.  Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.

Authors:  Zeneng Wang; W H Wilson Tang; Jennifer A Buffa; Xiaoming Fu; Earl B Britt; Robert A Koeth; Bruce S Levison; Yiying Fan; Yuping Wu; Stanley L Hazen
Journal:  Eur Heart J       Date:  2014-02-03       Impact factor: 29.983

8.  The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.

Authors:  Andrew Mente; Kenneth Chalcraft; Handan Ak; A Darlene Davis; Eva Lonn; Ruby Miller; Murray A Potter; Salim Yusuf; Sonia S Anand; Matthew J McQueen
Journal:  Can J Cardiol       Date:  2015-06-25       Impact factor: 5.223

9.  Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry.

Authors:  Zeneng Wang; Bruce S Levison; Jennie E Hazen; Lillian Donahue; Xin-Min Li; Stanley L Hazen
Journal:  Anal Biochem       Date:  2014-04-01       Impact factor: 3.365

10.  Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.

Authors:  Michael Lever; Peter M George; Sandy Slow; David Bellamy; Joanna M Young; Markus Ho; Christopher J McEntyre; Jane L Elmslie; Wendy Atkinson; Sarah L Molyneux; Richard W Troughton; Christopher M Frampton; A Mark Richards; Stephen T Chambers
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

View more
  12 in total

Review 1.  Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

Review 2.  The Gut-Brain Axis, BDNF, NMDA and CNS Disorders.

Authors:  Raeesah Maqsood; Trevor W Stone
Journal:  Neurochem Res       Date:  2016-08-23       Impact factor: 3.996

3.  Gut Microbial-Related Choline Metabolite Trimethylamine-N-Oxide Is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection.

Authors:  Zhilei Shan; Clary B Clish; Simin Hua; Justin M Scott; David B Hanna; Robert D Burk; Sabina A Haberlen; Sanjiv J Shah; Joseph B Margolick; Cynthia L Sears; Wendy S Post; Alan L Landay; Jason M Lazar; Howard N Hodis; Kathryn Anastos; Robert C Kaplan; Qibin Qi
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

Review 4.  Gut microbial metabolites associated with HIV infection.

Authors:  Zheng Wang; Qibin Qi
Journal:  Future Virol       Date:  2019-05-15       Impact factor: 1.831

Review 5.  The gut microbiome and HIV-1 pathogenesis: a two-way street.

Authors:  Stephanie M Dillon; Daniel N Frank; Cara C Wilson
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

Review 6.  Gut microbiome in chronic kidney disease: challenges and opportunities.

Authors:  Anitha Nallu; Shailendra Sharma; Ali Ramezani; Jagadeesan Muralidharan; Dominic Raj
Journal:  Transl Res       Date:  2016-04-30       Impact factor: 7.012

Review 7.  Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease.

Authors:  Mohamed El-Far; Cécile L Tremblay
Journal:  Curr Opin HIV AIDS       Date:  2018-01       Impact factor: 4.283

8.  Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.

Authors:  Judith M Haissman; Anna K Haugaard; Sisse R Ostrowski; Rolf K Berge; Johannes R Hov; Marius Trøseid; Susanne D Nielsen
Journal:  BMC Infect Dis       Date:  2017-06-23       Impact factor: 3.090

Review 9.  Gut microbiota in coronary artery disease: a friend or foe?

Authors:  Bo Zhang; Xinxin Wang; Ran Xia; Chunsheng Li
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 10.  Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases.

Authors:  Tiffany R Butterfield; Alan L Landay; Joshua J Anzinger
Journal:  Curr HIV/AIDS Rep       Date:  2020-04       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.